Mammalian housekeeping promoters represent a class of regulatory elements different from those of tissuesspecific genes, lacking a TATA box and associated with CG-rich DNA. We have compared the organization of the housekeeping Htf9 promoter In different cell types by genomic footprinting. The sites of in vivo occupancy clearly reflected local combinations of tissue-specific and ublqitous binding factors. The flexibility of the Htf9 promoter in acting as the target of cell-specific combinations of factors may ensure ubiquitous expression of the Hf/9-assoclated genes.
INTRODUCTION
Over 10.000 genes in higher eukaryotes are thought to encode proteins with 'housekeeping' functions, which are required for survival, growth and duplication of all cells. Such genes are active in all developmental stages and tissues, despite the differences in the transcriptional apparatus of different cell types. Mammalian housekeeping promoters lie within 1-2 kb CG-rich DNA stretches (1) (2) , exceeding by far the average promoter size. Functional studies indicate that they represent a class of regulatory elements distinct from those of tissue-specific genes. An obvious difference is the absence of the TATA box, which results in heterogeneous transcription initiation (1) often on both DNA strands (3) (4) (5) . On the other hand, elements that are potential targets of factors with CG-rich recognition sequences (such as Spl, AP2, MLTF or E2F) occur frequently.
The mouse Htf9 locus contains a typical housekeeping promoter (3) shared by two genes, Htf9a and Htf9c, that are transcribed from complementary DNA strands in opposite directions. Both genes are evolutionary conserved, and their expression in all tissues and cell lines suggests that they both encode proteins with basic functions (6) . The Htf9a gene is the mouse homolog of a novel yeast gene (SFO1) recently identified in a search for mutations suppressing the mating deficiency of fusl mutants, which are defective in cell fusion (J.Trueheart and J.Thorner, manuscript in preparation). The product of the Htf9c gene remains unidentified.
In a previous study the Htf9 promoter was characterized by combining protein-binding and deletion mapping assays (7, 8) .
The results indicated two novel features of this promoter. Firstly, we identified multiple factor-binding sites resulting in a complex architecture, yet only a subset was required for expression of a reporter gene in both orientations (7) : thus the Htf9 promoter elements were redundant. This characterization is consistent with results obtained from deletion analysis of unrelated housekeeping promoters (5, (9) (10) (11) (12) , whose transcriptional activity is also confined to short DNA fragments. Secondly, alternative promoter elements were required for activity in different cell types (8) . We have hypothesized that different elements are trans-activated in a cell-specific manner by factors varying from type to type: thus, the apparent redundancy of binding sites might in fact provide the structural basis for ubiquitous expression.
To assess this hypothesis we have examined the organization of the native#(/9 promoter in different cells by genomic footprinting. The results presented here show that the interactions between factors and single Htj9 elements in vivo differ in cell lines of different origin and with different levels of specialization. This gives rise to different combinations, involving both ubiquitous and cell-specific factors, which are assembled in a cell type-specific manner.
MATERIALS AND METHODS

CeU lines
The following cell lines were used: mouse C3H/10 T 1/2 (ATCC CCL 226) and NIH/3T3 fibroblasts (ATCC CRL 1658), rat C6 glioma (ATCC CCL 107), mouse S-20Y neuroblastoma (13), rat H4-H-E-C3 hepatoma (ATCC CRL 1600) and human HepG2 hepatocyte carcinoma cells (ATCC HB 8065). Cells were grown in D-MEM medium supplemented with L-glutamine and 10% fetal calf serum under 5% CO2. Growth conditions for the embryonic stem cell line CP1 and inhibition of differentiation with differentiation inhibitory activity (DIA/LIF) were described in (14) .
Gel-shift assays Protein extracts were prepared following published methods (15, 16) . Gel shift assays were carried out as previously described (7, 8) using routinely 1.10 4 cpm of end-labeled probe and 1 ng of double-stranded poly (dl.dC) as a non-specific competitor.
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In vivo footprinting The protocol for genomic footprinting using ligation-mediated PCR (LM-PCR) (17) was kindly provided by G. Pfeiffer and generally followed. Cell monolayers were exposed to dimethyl sulfate (DMS) concentrations ranging from 0.05% to 0.5%. In most experiments the effective concentrations fell between 0.1 and 0.3%. Following exposure to DMS cells were collected and DNA extracted by standard methods. After piperidine cleavage the DNA was processed for LM-PCR. To circumvent compressions or stops in regions of high guanine content, Sequenase was replaced with Taq polymerase in the extension step and the temperature was raised to 74°C. PCR-amplified products were run on 60 cm gradient gels and electroblotted onto GeneScreen (Dupont) membranes (18) . DNA was UV crosslinked under a 30 Watt lamp from a 80 cm-distance. Singlestranded probes were prepared by primer extension using 4 /ig of pH9.2 plasmid containing Htf9 annealed to 0.5 pmol of the appropriate primer, in the presence of 100 /tM dNTPs, 50 /tCi of a-32 P-dCTP and Sequenase. Filters were hybridized and washed as described in (18) . In experiments with whole tissues and DNAse I as the cleaving agent nuclei were isolated through polyamine-free sucrose gradients (19) . DNase I digestions and terminal-transferase reactions before LM-PCR were carried out as described in (20) . 
Oligonucleotides
RESULTS
The mouse Ht/9 locus contains two divergent genes that are both ubiquitously transcribed from a shared bidirectional promoter (3). In the promoter region ( Fig. 1 ) several factor-binding sites were identified in vitro (7) . Transient expression assays showed that the CCAAT box was a major promoter element in hepatoma cells while being dispensable in fibroblasts; conversely, a major contribution of the Spl.2 site to the overall promoter activity was observed in fibroblasts (8) . To establish wheter these different requirements reflected cell-type specific patterns of transactivation, we compared the in vivo interactions of nuclear factors with the Htf9 promoter in different cell lines. To this aim cells were subjected to in vivo footprinting aided by ligation-mediated PCR. Cell lines with different biological characteristics and transcriptional abilities were chosen, though the process of in vitro adaptation may have somewhat quenched the original differences between cell types. The following lines were examined: NTH/3T3 and C3H/10T 1/2 cells, independently derived from mouse embryonic fibroblasts, with the 10T 1/2 cells retaining a broader pluripotency; rat liver hepatoma H4-H-E-C3 cells, expressing a large number of hepatic functions, such as albumin, tyrosine aminotransferase, transferrin, prothrombin; rat C6 cells, derived from a glial tumor and expressing the S-100 protein, typycal of vertebrate neural tissues; mouse S-20Y cells, a cholinergic neuroblastoma line retaining the choline acetyltransferase enzymatic activity (13); mouse CP1 embryonic stem cells, whose differentiation was prevented by differentiation inhibitory activity DIA/LJF (14) . DMS titraticm experiments were initially carried out to establish the effective concentrations in each cell line and for particular sites. Thereafter three concentrations were routinely used in each experiment and a trend analysis enabled us to appreciate the protection of individual sites.
Protected Htf9 elements in H4-II-E-C3 hepatoma cells
The in vivo pattern of the Htf9 promoter in hepatoma nuclei is shown in Fig. 2 . A protection was observed at position 859-875, overlapping one major transcriptional origin of both divergent genes. The protected element consisted of a direct repeat (GGG-ACTGGGGACTGGGG) recognized by a novel factor called Gbinding factor, GBF (8; G. Di Matteo and P. L., unpublished). In vivo the element was protected on both strands and the binding was accompanied by the appearance of an additional band (position 856) at the 5' edge of the protection ( Fig. 2A) .
Another footprint was evident over the sequence GAGCC-AATAAAGCTA (position 911 -925), harboring a CCAAT box ( Fig. 2A and 2B ). The protection was flanked by hypersensitive bands on either side (positions 940 and 914 respectively, Fig. 2B ). Fig. 2C shows the CCAAT site in different cell lines: a distinct footprint was seen in H4 cells only. Because H4 cells are derived from rat hepatoma, rat DNA was sequenced in vivo to assess any divergence which may have occurred between mouse and rat: in the rat sequence one A to G transition (position 926) was found 5' to, but not affecting, the CCAAT site. Rat C6 cells, derived from a glial tumor, were also analysed as a species-specific control: no CCAAT protection was observed (Fig. 2Q . On the other hand, a footprint of similar extension to that seen in H4 cells was mapped in mouse liver nuclei using DNase I (not shown): thus the CCAAT protection is indeed restricted to cells of hepatic origin regardless of the species. The potential binding ability of the CCAAT site was assessed in gel-shift assays. A synthetic 26-mer copied from the protected CCAAT window gave an identical shift upon incubation with all extracts (not shown); however, when we assayed a 40 bpfragment (probe 2 in Fig. 1 ) carrying flanking sequences on both sides of the CCAAT box, both ubiquitous and hepatocyteenriched protein complexes were detected (Fig. 2D) : thus the Htf9 sequences surrounding the core CCAAT box participate in stabilizing the binding of a hepatic factor. Several hepatic CCAAT-binding factors are known (21, 22) . The largest family of liver-enriched factors includes the c/EBP protein group (22) , whose binding specificity includes CCAAT boxes, the enhancer core motif and c-AMP response elements. We have established that the Htf9-CCAAT factor does not belong to the c/EBP family by site-specific competition assays (Fig. 2D) , but have not pursued its identity any further.
Finally, a distinct footprint was seen at positions 964-974 (Fig. 2B) protecting the sequence TTTGGCGG, which matches a high-affinity site for the plOS^/F^F complex (23) . The protection was also visible on the complementary strand (not shown). 
Protected Htf9 elements in 3T3 and 10 T 1/2 fibroblasts
In both 3T3 and 10T 1/2 fibroblast lines protection of the GBFbinding site was visible on both strands (Fig. 3A and 3B ), as in hepatoma cells. Three potential Spl sites occur in the Htf9 promoter (see map in Fig. 1 ). No interaction was seen with site Spl.l, whose sequence matches a reported medium-affinity binding site (24) . On the other hand, sites Spl.2 (CTCCGCCCCC, 840-849) and Spl.3 (CCCGCCCC, 950-957) both match high-affinity sites for Spl (24) . In vitro binding of fibroblast extracts to both Htf9 sites was very efficient and was competitively inhibited by an excess of Spl-binding oligonucleotide. In vivo protection of both sites Spl.2 ( Fig. 3B ) and Spl.3 ( Fig. 3Q was evident on the G-rich lower strand. The region surrounding site Spl.3 showed an altered organization compared to the control ladder on the lower strand. Three footprints were individually distinguishable (Fig.3Q . Inspection of the DNA sequence (Fig. 1Q revealed close recognition sites for known factors: site Spl.3 (950-957) was preceded by the E2F-binding sequence TTTGGCGG (964-974) on the lower strand; the latter overlapped with a potential AP2-binding site (976-985) on the complementary strand. Sitespecific competition assays were carried out to disentangle the binding events: binding to Htf9-probe 3 (see Fig. IB 
Protected Htf9 elements in S-20Y neuroblastoma cells
In S-20Y neuroblastoma nuclei the GBF-binding site was fully protected on both strands and was bordered by the characteristic 5' band seen in all other cell lines (Fig. 4A-B ). Adjacent to that site an element of similar sequence (TGATTC, position 895-900) to the recognition site for API (TGAGTC) occurs, which was found to be a genuine API-binding site by gel-shift assays using a specific competitor (not shown). The API site was protected and flanked by hypersensitive bands in S-20Y cells (Fig. 4A -B) . No protection was seen in other examined cell lines (Fig. 4Q .
The target sites for Spl and E2F showed a similar in vivo occupancy to that observed in fibroblast cells: both Spl sites were protected on the lower strand (Fig. 4A) ; the E2F site was protected on both strands (Fig. 4A-4B) ; adjacent footprints at sites E2F, Spl.3 and G 936 on the lower strand generated an in vivo ladder similar to that seen in fibroblasts (compare Fig. 3C  and 4A ).
Protected Htf9 elements in CP1 embryonic stem cells
In all somatic cell lines examined thus far the GBF site had been found to be similarly protected in vivo. An exception is represented by the CP1 embryonic stem cell line, in which no GBF footprint was detected (Fig. 5A) ; the adjacent Spl.2 site was protected by an independent binding event on the lower strand. In vitro assays confirmed that embryonic cell extracts do not in fact express GBF (Fig. 5B) . The pattern of the Spl.3/E2F region in undifferentiated CP1 cells also differed from that seen in other cell types: site Spl.3 was protected on the the lower strand as in fibroblasts and neuroblastoma cells (Fig. 4C) ; in contrast the E2F site was not protected: therfore the lower strand footprint was of limited extension, and no protection at all was seen on the complementary strand. Fig. 5C shows that the lack of E2F protection is characteristic of ES cells.
DISCUSSION
During the process of differentiation and development the pool of transcription factors is diversified in different cell types. In addition the availability of the so-called general factors also fluctuates, as single promoters have different requirements for the factors involved in basal complexes (25) . Housekeeping promoters are ubiquitously active despite these variations. In vitro evidence for cell-specific interactions was reported for the promoters of the Htf9 (8), aldolase (26), B-polymerase (27) and Na,K-ATPase (28) housekeeping genes. Based on the in vitro results, one can predict that the trans-activated elements in housekeeping promoters vary from cell to cell: ubiquitous expression will result from cell-specific patterns of transcriptional activation.
Genomic footprinting provides the most reliable picture of the interactions occurring within the cell (rev. 29) and has proved extremely powerful in pinpointing the onset of activation in inducible (30) (31) (32) and developmental^ regulated genes (18, (33) (34) (35) . The technique has also depicted the alternative organization of the X-linked PGK promoter in its active and inactive state (20, 36) . In these studies the occupancy of critical cis-active sequences appeared to be an all-or-nothing event related to the acquisition of an open chromatin conformation which triggered transcription. We have employed genomic footprinting to study the native organization of the Htf9 promoter. We have regarded as informative the Htj9 sites showing unambiguous protections in at least one cell type-though these may not represent the only functionally relevant elements-and have compared their status in cells expressing different specialized functions. An important point emerging from this study is that in vivo protections of the Htj9 promoter reflected cell type-specific combinations of factors. In contrast, in vitro studies using isolated promoter elements often reflected all potential binding events.
Htf9, like most housekeeping promoters, lacks a TATA box; TATA-less promoters are thought to assemble transcriptional complexes via interactions differing from those occurring at TATA-containing promoters (37) and involving distinct initiators which are only beginning to be identified (38, 39) . In this study one major divergent origin of transcription, coinciding with the GBF-binding element, was found to be fully protected on both strands in all differentiated cell lines. The GBF element is included in the shortest DNA fragment required for transcription in both orientations (7) . Protection of the GBF site was accompanied by the appearance of a flanking band, which might either indicate a displacement of the G residue 856 at the 5' border of the protected she, or cleavage of an exposed adenine at position 857, which would also be methylatable by DMS. Both possibilities suggest an altered chromatin structure around the transcription start site. It is noteworthy that the preferrred site of Ht9-a RNA initiation is located exacdy at 857 (3). It is possible that GBF is a novel member of the protein group involved in transcription initiation in the absence of a TATA box-this question is currently being addressed in our laboratory. Embryonic stem cells, which are the only type lacking GBF, are known to express specific variants of certain 'somatic' factors: the elements required for promoter activity often differ in embryonic and differentiated cells. It will be interesting to ask whether the absence of GBF alters transcription initiation of the Htf9-transcripts in ES cells.
The Htj9 promoter carries a CCAAT box in the orientation of the Htf9-a gene transcripition. Deletion of the CCAAT box is detrimental for transcription in hepatocytes but not in fibroblasts; in addition the Htf9-CCAAT box can replace the endogenous CCAAT box in the albumin promoter (8) . The results reported here show in vivo occupancy of the CCAAT box in the nuclei from rat hepatoma and from mouse liver. Retention of the footprint during liver nuclei isolation-a procedure during which most factors fall off their target sites (19)-suggests that the interaction is remarkably stable.
On the other hand, a promoter fragment containing only the GBF and Spl.2 sites was previously found to be sufficient for high expression in fibroblasts. In the present study site Spl.2 appeared to be effectively protected on the lower strand. The presence of one single guanine in the site made the protection difficult to assess on the upper strand, thus we could not establish whether the asymmetrical footprint at the Spl.2 site reflects a technical or a biological feature. Site Spl.2 was footprinted in several cell lines (3T3, 10T 1/2, S-20Y and ES cells) but not in hepatoma cells: it is possible that the simultaneous binding of GBF and of a CCAAT-binding factor in hepatoma nuclei generates a steric hindrance incompatible with the further binding of Spl to site Spl.2. Fig. 6 schematically summarizes the hepatocyte-type and fibroblast-type organization of the Htf9 promoter: together the in vivo footprinting data are consistent with, and retrospectively provide an explanation for, the results of expression assays in mammalian cell types.
A few novel promoter features have also emerged from this study. A cell-type restricted interaction was seen at the API site in S-20Y cells though no functional analysis was carried out in this cell line. The footprint did not require TPA-induction as reported for the in vivo binding of API to the c-fos promoter (40) . The footprint might be due to a neuronal API subtype indistinguishable from the API factor in gel-shift assays, or to the interaction of neuronal factor(s) with API (or the API-related protein) which might stabilize the binding to the Htf9 promoter.
The distal promoter region showed an interesting organization, which has not yet been functionally dissected but may have a significant role in control of Htf9-a transcription. A complex pattern was seen in neuroblastoma and fibroblast cells. Alternating hypersensitive and protected elements indicated that more than one protein were involved in the footprint. Spl was one of the factors involved and protected the Spl.3 box on the lower strand in fibroblasts, neuroblasts and embryonic stem cells-the site could not be unambiguously resolved in hepatoma nuclei because of its compression between the E2F and CCAAT protections. The element TTTTGGCGGG was also protected in fibroblasts and neuroblastoma cells. The protected site represents a perfect match to sites selected in vitro by complexes containing the pl05 RB (retinoblastoma) protein (23)-to which the E2F factor is also thought to associate-and is identical to the E2F site in the c-myb promoter (rev. 41). The involvement of E2F is compatible with the lack of protection in undifferentiated embryonic stem cells, as published evidence reported very low levels of the embryonal E2F-like factor DRTF1 in teratocarcinoma cells prior to retinoic acid-induced differentiation (42-43). To our knowledge this is the first demonstration of the in vivo occupancy of an E2F-binding site in proliferating cells. In the light of our observations that Htf9-a is expressed in cycling cells in which the plOS 113 protein was sequestrated by the E1A oncogene, while being repressed in cells transfected with E1A mutants failing to interact with plOS^A.Bressan, M.Caruso, A.Felsani and P.L., unpublished), occupancy of the plOS^/ElF target is very intriguing.
In fibroblast and neuroblastoma nuclei the promoter ladder appeared to be altered beyond site Sp 1.3 on the lower strand. No corresponding alteration was seen on the upper strand, which parallels the strand-specificity of the Spl.3 footprint. The altered organization was apparent in cell types in which both Spl .3 and E2F-binding sites were occupied, and in our opinion may reflect a local distortion resulting from the simultaneous binding of E2F and Spl to adjacent sites, rather than the binding of a novel protein to an independent sequence. Spl .3 and E2F are separated by the sequence 5'-GGAAGCGCGG-3', which is part of the recently described SCE element separating the CG-box 1 from the E2F site in the dhfr promoter (44) . The SCE is not a proteinbinding site, yet exerts a repressive function and is thought to generate a distortion of the DNA structure characteristically framed by hypersensitive sites: this would prevent the 'crosstalk' between the Spl and E2F proteins when dhfr expression is not required. It is tempting to suggest that the altered structure in the distal region of Htf9 also indicates an element of structural distortion which could serve a similar function and inhibit Htf9-a expression in GO cells.
Our current understanding of transcriptional regulation is based on combinatorial models. TheHtf9 promoter shows an intrinsic flexibility to act as the target of different combinations of factors, which may enable it to direct transcription in cells equipped with different transcriptional machineries. The cooperation between cell-specific and ubiquitous factors in activating different sets of regulatory elements may represent a generalised mechanism maintaining the ubiquitous expression of housekeeping functions during differentiation.
